Articles in section Opinion & Analysis

<< Mergers & Acquisitions

35 articles

Research & Development >>

Pages 1 2 3 4

Next >>

IQVIA Pharma Deals Half-Year Review of 2024 Published: 17 Sep-2024
By: Lucy Haggerty, Taskin Ahmed, Ayush Saxena & Swati Sharan
Abstract Fulltext:
Volume: 2024 Issue: 9
IQVIA Pharma Deals Review of 2023 Published: 28 Mar-2024
By: Lucy Haggerty, Ayush Saxena & Taskin Ahmed
Abstract Fulltext:
Volume: 2024 Issue: 3
IQVIA Pharma Deals Half-Year Review of 2023 Published: 7 Oct-2023
By: Lucy Haggerty,Swati Sharan & Taskin Ahmed
Abstract Fulltext:
Volume: 2023 Issue: 10
M&A Activity Starts to Pick up in Q2 2023 Published: 27 Apr-2023
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2023 Issue: 4
IQVIA Pharma Deals Review of 2022 Published: 15 Mar-2023
By: Heather Cartwright, Taskin Ahmed & Lucy Haggerty
Abstract Fulltext:
Volume: 2023 Issue: 3
Early Signs of M&A Activity Heating Up in 2023 Published: 19 Jan-2023
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2023 Issue: 1
Busy Start to Q4 in M&A Deal Making Published: 1 Nov-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 11
IQVIA Pharma Deals Half-Year Review of 2022 Published: 14 Oct-2022
By: Heather Cartwright, Taskin Ahmed & Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 10
Could Biopharma M&A Activity be on the Rise? Published: 12 Aug-2022
By: Lucy Haggerty & Taskin Ahmed
Abstract Fulltext:
Volume: 2022 Issue: 8
IQVIA Pharma Deals Review of 2021 Published: 16 Mar-2022
By: Heather Cartwright, Taskin Ahmed & Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 3

Login

Username:

Password:

Keep me logged in